Nautilus Biotechnology: Contrarian Proteoformics Play After Recent Pullback (NASDAQ:NAUT)
· seekingalpha.com
NAUT shifts to targeted proteoform assays as broadscale plans falter; Voyager roadmap improves.
Nautilus Biotechnology, Inc. ( NAUT ) is a development-stage life sciences company that's developing the Voyager platform. They recently reported Q2 results , a...